Molecular, cellular and medical aspects of the action of nutraceuticals and small molecules therapeutics: From chemoprevention to new drug development

Drugs under Experimental and Clinical Research

Volumn 28, Issue 5, 2002, Pages 169-175

  Colic, M ^a   Pavelic, K ^b  

^a Molecutec Corporation   (United States)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTHOCYANIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CURCUMIN; EPHEDRA EXTRACT; EPHEDRINE; FLAVONOID; FLAVOPIRIDOL; GAMMA BUTYROLACTONE; GARLIC EXTRACT; GENISTEIN; GINKGO BILOBA EXTRACT; GLYCYRRHIZA EXTRACT; GREEN TEA EXTRACT; HYPERICUM PERFORATUM EXTRACT; LYCOPENE; NATURAL PRODUCT; PHENYLPROPANOLAMINE; PLANT EXTRACT; QUERCETIN; SILYBUM MARIANUM EXTRACT; SILYMARIN; THIOCTIC ACID;

ARTICLE; AUTOIMMUNE DISEASE; BRAIN DISEASE; CANCER; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COMA; CONVULSION; DIET SUPPLEMENTATION; DRUG DESIGN; DRUG FATALITY; DRUG INDUSTRY; DRUG MARKETING; EOSINOPHILIA MYALGIA SYNDROME; FOOD; FOOD AND DRUG ADMINISTRATION; FOOD DRUG INTERACTION; GENE EXPRESSION; HUMAN; MOLECULE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIENT; RISK BENEFIT ANALYSIS; SIGNAL TRANSDUCTION; STROKE;

AUTOIMMUNE DISEASES; BRAIN DISEASES; CARDIOVASCULAR DISEASES; CHEMOPREVENTION; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; HUMANS; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 0037004996     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dietary Supplement Health and Education Act (DSHEA, Public Law 103-417, 25 October 1994; Codified at 42 USC 287C-11).
2. Zeisel S.H. Regulation of "nutraceuticals". Science, 285, 1853, 1999.
3. Moore L, B., Goodwin B., Jones S.A. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad. Sci. USA, 97, 7500, 2000.
4. Obach R.S. Inhibition of human cytochrome P450 enzymes by constituents of St. John's wort, an herbal preparation used in the treatment of depression. J. Pharmacol Exp. Ther., 294, 88, 2000.
5. Food and Drug Administration, Proposed rule, Dietary supplements containing ephedrine alkaloids. Fed. Regist., 62, (4 June 1997; 1977 and 25, 6 February, 5699, 1997) Pp 107, 30677.
6. Croce C.M. How can we prevent cancer? Proc. Natl. Acad. Sci. USA, 98, 10986, 2001.
7. Colic M., Pavelic K. Molecular mechanisms of anticancer activity of natural dietetic products. J. Mol. Med., 78, 333, 2000.
8. Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem. Pharmacol., 60, 1051, 2000.
9. Gupta S., Hastak K., Ahmad N., Levin J.S., Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. USA, 98, 10350, 2001.
10. Wolf C.R. Chemoprevention: Increased potential to bear fruit Proc. Natl. Acad. Sci. USA, 98, 2941, 2001.
11. Aviram M. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins. Antiox Redox Signal 1, 585, 1999.
12. Aviram M. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: Studies in atherosclerotic mice and in humans. Dru. Exp. Clin. Res., 2/3, 49, 2002.
13. Kaneto H., Kajimoto Y., Miyagawa J, et al. Beneficial effects of antioxidants in diabetes: Possible protection of pancreatic beta-cells against glucose toxicity. Diabetes, 48, 2398, 1999.
14. Tanaka Y., Gleason C.E., Tran P.O.T., Harḿon J.S., Robertson P. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc. Natl. Acad Sci. USA, 96, 10857, 1999.
15. Matsuoka T, Kajimoto Y., Watada H., et al. Glycation-dependent, reactive oxygen species - mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Invest., 99, 144, 1997.
16. Tiedge M., Lortz S., Munday R., Lenzen S. Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes, 47, 1578, 1998.
17. Weinreb L., Maor G., Youdim M.B., Mandel S. Green tea polyphenol(-) epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem., 78, 1073, 2001.
18. Watanabe C.M.H., Wolffram S., Ader P., et al. The in vivo neuromodulatory effects of the herbal medicine gingko biloba. Proc. Natl. Acad. Sci. USA, 98, 6577, 2001.
19. Grunblatt E., Mandel S, Youdim M.B. Neuroprotective strategies in Parkinson's disease using the model of 6-hydroxydopamine and MPTP. Ann. NY Acad. Sci., 899, 262, 2000.
20. McCulloch J., Dewar D. A radical approach to stroke therapy. Proc. Natl. Acad Sci. USA, 98, 10989, 2001.